Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Raymond James Financial ( (RJF) ) just unveiled an announcement.
On December 3, 2025, Raymond James Financial announced an 8% increase in its quarterly dividend for common stock, raising it to $0.54 per share, payable on January 16, 2026. The company also declared a quarterly dividend for its Series B Preferred Stock and authorized a $2 billion share repurchase program, replacing the previous $1.5 billion authorization. This move reflects the company’s strategy to enhance shareholder value and optimize its capital structure.
The most recent analyst rating on (RJF) stock is a Buy with a $176.00 price target. To see the full list of analyst forecasts on Raymond James Financial stock, see the RJF Stock Forecast page.
Spark’s Take on RJF Stock
According to Spark, TipRanks’ AI Analyst, RJF is a Outperform.
Raymond James Financial’s overall stock score of 76 reflects its strong financial performance and positive earnings call highlights, including record revenues and strategic investments. However, technical indicators suggest a bearish trend, and valuation metrics indicate the stock is fairly priced, contributing to a balanced outlook.
To see Spark’s full report on RJF stock, click here.
More about Raymond James Financial
Raymond James Financial, Inc. (NYSE: RJF) is a leading diversified financial services company providing private client group, capital markets, asset management, banking, and other services to individuals, corporations, and municipalities. The firm, public since 1983, is listed on the New York Stock Exchange and manages total client assets of $1.75 trillion.
Average Trading Volume: 1,229,107
Technical Sentiment Signal: Buy
Current Market Cap: $30.61B
For a thorough assessment of RJF stock, go to TipRanks’ Stock Analysis page.

